{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:34:59Z","timestamp":1789824899593,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.antiviral.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T17:42:52Z","timestamp":1538070172000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Inhibition of adenovirus infection by mifepristone"],"prefix":"10.1016","volume":"159","author":[{"given":"Jos\u00e9 A.","family":"Marrugal-Lorenzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7142-0315","authenticated-orcid":false,"given":"Ana","family":"Serna-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bu\u00f1uales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7830-6371","authenticated-orcid":false,"given":"Joanna","family":"Poutou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Gonzalez-Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-2598","authenticated-orcid":false,"given":"Ruben","family":"Hernandez-Alcoceba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-1979","authenticated-orcid":false,"given":"Javier","family":"S\u00e1nchez-C\u00e9spedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.09.011_bib1","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1128\/JVI.77.24.13275-13287.2003","article-title":"Association of adenovirus with the microtubule organizing center","volume":"77","author":"Bailey","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060201","article-title":"Designer oncolytic adenovirus: coming of age","volume":"10","author":"Baker","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.antiviral.2018.09.011_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40842-016-0033-9","article-title":"Update on medical treatment for Cushing's disease","volume":"2","author":"Cuevas-Ramos","year":"2016","journal-title":"Clin. Diabetes Endocrinol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/med.21311","article-title":"The unique pharmacological characteristics of mifepristone (RU486): from terminating pregnancy to preventing cancer metastasis","volume":"34","author":"Chen","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"11","key":"10.1016\/j.antiviral.2018.09.011_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.molmed.2016.09.006","article-title":"Drug repurposing: new treatments for zika virus infection?","volume":"22","author":"Cheng","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.antiviral.2018.09.011_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0166-3542(02)00077-3","article-title":"Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn","volume":"55","author":"Cheng","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.09.011_bib7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.09.011_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004584","article-title":"Identification of trypanocidal activity for known clinical compounds using a new trypanosoma cruzi hit-discovery screening cascade","volume":"10","author":"De Rycker","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2018.09.011_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CMR.00052-07","article-title":"Adenoviruses in immunocompromised hosts","volume":"21","author":"Echavarria","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2018.09.011_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/07357900601062339","article-title":"Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma","volume":"24","author":"Grunberg","year":"2006","journal-title":"Canc. Invest."},{"key":"10.1016\/j.antiviral.2018.09.011_bib11","unstructured":"HAdV_Working_Group, 2018. http:\/\/hadvwg.gmu.edu\/."},{"key":"10.1016\/j.antiviral.2018.09.011_bib12","series-title":"Adenoviridae and Their Replication","first-page":"771","author":"Horwitz","year":"1991"},{"key":"10.1016\/j.antiviral.2018.09.011_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0006-2952(96)00357-7","article-title":"Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes","volume":"52","author":"Jang","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171687","article-title":"Etiology of severe pneumonia in Ecuadorian children","volume":"12","author":"Jonnalagadda","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2018.09.011_bib15","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3201\/eid2204.151403","article-title":"Severe infections with human adenovirus 7d in 2 adults in family, Illinois, USA, 2014","volume":"22","author":"Kajon","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.09.011_bib16","doi-asserted-by":"crossref","first-page":"10122","DOI":"10.1128\/JVI.78.18.10122-10132.2004","article-title":"Cytoplasmic dynein mediates adenovirus binding to microtubules","volume":"78","author":"Kelkar","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1124\/dmd.30.9.985","article-title":"Differential oxidation of mifepristone by cytochromes P450 3A4 and 3A5: selective inactivation of P450 3A4","volume":"30","author":"Khan","year":"2002","journal-title":"Drug Metabol. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.antiviral.2018.09.011_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0022-4731(87)90160-9","article-title":"Pharmacokinetics and metabolism of RU 486","volume":"27","author":"Lahteenmaki","year":"1987","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.antiviral.2018.09.011_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/10430340050016238","article-title":"Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis","volume":"11","author":"Leopold","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.antiviral.2018.09.011_bib20","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2010-04-259291","article-title":"How I treat adenovirus in hematopoietic stem cell transplant recipients","volume":"116","author":"Lindemans","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2018.09.011_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2018.09.011_bib22","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/JVI.16.3.696-706.1975","article-title":"Adenovirus binds to rat brain microtubules in vitro","volume":"16","author":"Luftig","year":"1975","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib23","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.drudis.2015.07.007","article-title":"Antiadenovirus drug discovery: potential targets and evaluation methodologies","volume":"20","author":"Martinez-Aguado","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2018.09.011_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.virusres.2015.05.025","article-title":"Against the clock towards new Ebola virus therapies","volume":"209","author":"Martinez-Romero","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2018.09.011_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/phar.1202","article-title":"Mifepristone for management of Cushing's syndrome","volume":"33","author":"Morgan","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.antiviral.2018.09.011_bib26","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1128\/JVI.02321-10","article-title":"Functional genetic and biophysical analyses of membrane disruption by human adenovirus","volume":"85","author":"Moyer","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.mt.6300048","article-title":"Enhancement of gene transfer to human myeloid cells by adenovirus-fiber complexes","volume":"15","author":"Nepomuceno","year":"2007","journal-title":"Mol. Ther. J. Am. Soc. Gene Therapy"},{"key":"10.1016\/j.antiviral.2018.09.011_bib28","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1128\/JVI.02471-09","article-title":"Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection","volume":"84","author":"Nguyen","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1208\/s12248-012-9423-9","article-title":"Target-mediated disposition model describing the dynamics of IL12 and IFNgamma after administration of a mifepristone-inducible adenoviral vector for IL-12 expression in mice","volume":"15","author":"Parra-Guillen","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.antiviral.2018.09.011_bib30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/adt.2015.0003.drrr","article-title":"Repurposing kinase inhibitors as antiviral agents to control influenza a virus replication","volume":"13","author":"Perwitasari","year":"2015","journal-title":"Assay Drug Dev. Technol."},{"issue":"2","key":"10.1016\/j.antiviral.2018.09.011_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01914-16","article-title":"Clinically approved ion channel inhibitors close gates for hepatitis C virus -and open doors for drug repurposing in viral infectious diseases","volume":"91","author":"Pietschmann","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.10.032","article-title":"Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment","volume":"268","author":"Poutou","year":"2017","journal-title":"J. Contr. Release Offic. J. Contr. Release Soc."},{"key":"10.1016\/j.antiviral.2018.09.011_bib33","first-page":"4","article-title":"A simple method of stimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2018.09.011_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virol.2003.11.028","article-title":"Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo","volume":"320","author":"Rivera","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.09.011_bib35","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1021\/acs.jmedchem.6b00300","article-title":"New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine derivatives as potential inhibitors of adenovirus infection. Synthesis, biological evaluation, and structure-activity relationships","volume":"59","author":"Sanchez-Cespedes","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.09.011_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.antiviral.2014.05.010","article-title":"Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative","volume":"108","author":"Sanchez-Cespedes","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.09.011_bib37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.antiviral.2018.09.011_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002549","article-title":"Transcriptional activation of the adenoviral genome is mediated by capsid protein VI","volume":"8","author":"Schreiner","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.09.011_bib39","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1128\/JVI.00557-08","article-title":"Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport","volume":"82","author":"Smith","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/104303403765255165","article-title":"Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice","volume":"14","author":"Smith","year":"2003","journal-title":"Hum. Gene Ther."},{"issue":"10","key":"10.1016\/j.antiviral.2018.09.011_bib41","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/1568026616666160930131737","article-title":"Repurposing of anticancer drugs for the treatment of bacterial infections","volume":"17","author":"Soo","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.09.011_bib42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.chom.2011.08.010","article-title":"Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection","volume":"10","author":"Strunze","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2018.09.011_bib43","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/emboj\/20.6.1310","article-title":"Adenovirus-activated PKA and p38\/MAPK pathways boost microtubule-mediated nuclear targeting of virus","volume":"20","author":"Suomalainen","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2018.09.011_bib44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1083\/jcb.144.4.657","article-title":"Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus","volume":"144","author":"Suomalainen","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib45","doi-asserted-by":"crossref","first-page":"848","DOI":"10.21037\/jtd.2016.03.38","article-title":"Severe adenovirus community-acquired pneumonia in immunocompetent adults: chest radiographic and CT findings","volume":"8","author":"Tan","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.antiviral.2018.09.011_bib46","article-title":"Severe community-acquired pneumonia caused by human adenovirus in immunocompetent adults: a multicenter case series","volume":"11","author":"Tan","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2018.09.011_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/bmc.1086","article-title":"Simultaneous determination of mifepristone and monodemethyl-mifepristone in human plasma by liquid chromatography-tandem mass spectrometry method using levonorgestrel as an internal standard: application to a pharmacokinetic study","volume":"23","author":"Tang","year":"2009","journal-title":"Biomed. Chromatogr. : BMC (Biomed. Chromatogr.)"},{"key":"10.1016\/j.antiviral.2018.09.011_bib48","first-page":"1241","article-title":"Determinations of mifepristone and its metabolites and their pharmacokinetics in healthy female Chinese subjects","volume":"46","author":"Teng","year":"2011","journal-title":"Yao xue xue bao = Acta Pharm. Sin."},{"key":"10.1016\/j.antiviral.2018.09.011_bib49","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","article-title":"HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses","volume":"94","author":"Tomko","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.09.011_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejogrb.2018.01.017","article-title":"Elective abortion: clinical practice guidelines from the French College of gynecologists and obstetricians (CNGOF)","volume":"222","author":"Vayssiere","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib51","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1016\/j.ijid.2011.02.006","article-title":"Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients","volume":"15","author":"Wiegering","year":"2011","journal-title":"Int. J. Infect. Dis. IJID Offic. Publ. Int. Soc. Infect. Diseases"},{"key":"10.1016\/j.antiviral.2018.09.011_bib52","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JVI.79.4.1992-2000.2005","article-title":"Adenovirus protein VI mediates membrane disruption following capsid disassembly","volume":"79","author":"Wiethoff","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib53","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jmv.21136","article-title":"Detection of a broad range of human adenoviruses in respiratory tract samples using a sensitive multiplex real-time PCR assay","volume":"80","author":"Wong","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2018.09.011_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13104-016-2370-2","article-title":"Severe community-acquired adenovirus pneumonia treated with oral ribavirin: a case report","volume":"10","author":"Yoon","year":"2017","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.antiviral.2018.09.011_bib55","first-page":"19051","article-title":"Clinical data analysis of 19 cases of community-acquired adenovirus pneumonia in immunocompetent adults","volume":"8","author":"Yu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218304595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218304595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T06:20:49Z","timestamp":1605075649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218304595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":55,"alternative-id":["S0166354218304595"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.09.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of adenovirus infection by mifepristone","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}